細胞検索

細胞検索
キーワード:
  

共通の情報

お願い

• メールでお問い合わせいただく場合は、タイトルの先頭に細胞の2文字の入力をお願い致します。
• MAIL NEWS送信にお申し込み下さい。
(新着情報等が配信されます)


各種お問い合わせ先

COVID-19 関連細胞

1)新型コロナウイルス感染症に対する理研BRCの取り組み

理研バイオリソース研究センター(理研BRC)は、遺伝子/細胞/マウス個体の三つの生命階層のリソースを1機関で取り揃えた、世界的にもユニークなリソース機関です。この特徴を活かして、新型コロナウイルス感染症の統合的な研究の促進のため、感染症の4つのステージ(①ウイルス感染・増殖、②発症・生体防御、③重症化、④治療・予防)の研究開発の鍵となるバイオリソースを収集・整備し、情報発信していきます。

COVID-19 関連マウスリソース(実験動物開発室)

SARS-CoV-2 relevant human genes(遺伝子材料開発室)


2)BRCから提供した細胞を利用した COVID-19 関連文献

 BRC ResourceReference
1RCB0485 LA-N-5 Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19
2RCB0209 SP2/0-Ag14 Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
3RCB0988 CACO-2
CSII-CMV-MCS-IRES2-Bsd
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells

3)COVID-19 研究のための細胞株

 BRC Cell LineCell LineReference
1Vero E6, RCB0001 Vero
RCB0988 CACO-2
Calu-3
RCB2202 293T
RCB1366 HuH-7
Vero E6
Caco-2
Calu-3
HEK293T
Huh7
In Vitro and Animal Models for SARS-CoV-2 research
2Vero E6
RCB0001 Vero
RCB1366 HuH-7
RCB2202 293T
RCB0098 A549, RCB3677 A549
EFKB3
Vero E6
Vero
HUH 7.0
293T
A549
EFKB3
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
3RCB0001 Vero
RCB0007 HeLa, RCB3680 HeLa
RCB2202 293T
RCB1366 HuH-7
Vero
HeLa
HEK293T/F
Huh7
A Thermostable mRNA Vaccine against COVID-19
4RCB1637 293
RCB2202 293T
RCB0098 A549, RCB3677 A549
RCB0218 MRC-5, known PDL
Vero E6, RCB0001 Vero
Vero 81
RCB0007 HeLa, RCB3680 HeLa
RCB1366 HuH-7
293
293T
A549
MRC5
Vero E6
Vero 81
HeLa
Huh7
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
5RCB1648 Hep G2
RCB1366 HuH-7
RCB2202 293T
RCB0001 Vero
CHO
RCB0995 MDCK
HepG2
Huh-7
293T
Vero
CHO
MDCK
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
6Vero E6, RCB0001 Vero
RCB1366 HuH-7
Vero E6
Huh-7
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
7Vero E6, RCB0001 Vero
RCB1366 HuH-7
Vero E6
Huh-7
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway
8Vero E6, RCB0001 Vero
RCB1366 HuH-7
Vero E6
Huh-7
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
9Vero E6, RCB0001 Vero
RCB1366 HuH-7
Vero E6
Huh-7
A pneumonia outbreak associated with a new coronavirus of probable bat origin
10RCB1637 293
RCB1366 HuH-7
RCB1423 BHK-21
Vero E6, RCB0001 Vero
HEK293
Huh-7
BHK21
Vero-E6
Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε
11RCB0007 HeLa, RCB3680 HeLa
RCB2202 293T
RCB1423 BHK-21
RCB0988 CACO-2
HeLa
293T
BHK-21
Caco-2
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
12RCB0988 CACO-2Caco-2Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
13RCB0988 CACO-2Caco-2A metabolic handbook for the COVID-19 pandemic
14RCB2202 293T
RCB0098 A549, RCB3677 A549
BHK
RCB0988 CACO-2
RCB1366 HuH-7
PK-15
293T
A549
BHK
Caco-2
Huh-7.5
PK-15
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
15RCB2202 293T
RCB0098 A549, RCB3677 A549
HEK293T
A549
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
16RCB2202 293T
RCB0007 HeLa, RCB3680 HeLa
Calu-3
RCB0218 MRC-5, known PDL
HEK293T
HeLa
Calu-3
MRC-5
Cell entry mechanisms of SARS-CoV-2
17RCB2202 293T
HEK293F
RCB0007 HeLa, RCB3680 HeLa
RCB0218 MRC-5, known PDL
HEK293T
HEK293F
HeLa
MRC5
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
18RCB1366 HuH-7
Huh-7.5
Huh-7
Huh-7.5
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
19RCB0994 MA104
RCB1637 293
MA104
HEK293
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
20RCB0218 MRC-5, known PDL MRC-5 Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells
21Fcwf-4
A72
RCB0995 MDCK
DH82
Fcwf-4
A72
MDCK
DH82
Establishment of a Virulent Full-Length cDNA Clone for Type I Feline Coronavirus Strain C3663
22GES-1
RCB1189 THP-1,RCB3686 THP-1
GES-1
THP-1
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels